Matrix metalloproteinase levels in children with aggressive periodontitis

Journal of Periodontology

Volumn 79, Issue 5, 2008, Pages 819-826

  Alfant, Barnett ^a   Shaddox, Luciana M ^a   Tobler, Jeffrey ^a   Magnusson, Ingvar ^a   Aukhil, Ikramuddin ^a   Walker, Clay ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Children; Metalloproteinases; Periodontitis

Indexed keywords

MATRIX METALLOPROTEINASE;

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CHRONIC DISEASE; CLASSIFICATION; COHORT ANALYSIS; COMPARATIVE STUDY; ENZYMOLOGY; GINGIVITIS; HOSPITALIZATION; HUMAN; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PERIODONTITIS; REFERENCE VALUE;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; CASE-CONTROL STUDIES; CHILD; CHRONIC DISEASE; COHORT STUDIES; GINGIVAL CREVICULAR FLUID; HUMANS; MATRIX METALLOPROTEINASES; MIDDLE AGED; PERIODONTITIS; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 44349168802     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2008.070513     Document Type: Article

References (38)

1. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006;69:562-573.
2. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463-516.
3. Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodeling. Nat Rev Mol Cell Biol 2007;8:221-233.
4. Uitto VJ, Overall CM, McCulloch C. Proteolytic host cell enzymes in gingival crevice fluid. Periodontol 2000 2003;31:77-104.
5. Leppert D, Lindberg RL, Kappos L, Leib SL. Matrix metalloproteinases: Multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Rev 2001;36:249-257.
6. Parks WC, Wilson CL, López-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004;4:617-629.
7. Kinane D, Podmore M, Murray M, Hodge P, Ebersole J. Etiopathogenesis of periodontitis in children and adolescents. Periodontol 2000 2001;26:54-91.
8. Reynolds J, Hembry R, Meikle M. Connective tissue degradation in health and periodontal disease and the roles of matrix metalloproteinases and their natural inhibitors. Adv Dent Res 1994;8:312-319.
9. Golub LM, McNamara TF, Ryan ME, et al. Adjunctive treatment with subantimicrobial doses of doxycycline: Effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol 2001;28:146-156.
10. Garlet G, Martins W, Fonseca B, Ferreira B, Silva J. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol 2004;31:671-679.
11. Kinane D. Regulators of tissue destruction and homeostasis as diagnostic aids in periodontology. Periodontol 2000 2000;24:215-225.
12. Hannas A, Pereira J, Granjeiro J, Tjäderhane L. The role of matrix metalloproteinases in the oral environment. Acta Odontol Scand 2007;65:1-13.
13. Golub LM, Siegel K, Ramamurthy NS, Mandel ID. Some characteristics of collagenase activity in gingival crevicular fluid and its relationship to gingival diseases in humans. J Dent Res 1976;55:1049-1057.
14. Golub L, Stakiw J, Singer D. Collagenolytic activity of human gingival crevice fluid. J Dent Res 1974;53:1501.
15. Kiili M, Cox S, Chen H, et al. Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: Molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J Clin Periodontol 2002;29:224-232.
16. Ilgenli T, Vardar-Sengul S, Gürkan A, et al. Gingival crevicular fluid matrix metalloproteinase-13 levels and molecular forms in various types of periodontal diseases. Oral Dis 2006;12:573-579.
17. Hernandez M, Valenzuela M, Lopez-Otin C, et al. Matrix metalloproteinase-13 is highly expressed in destructive periodontal disease activity. J Periodontol 2006;77:1863-1870.
18. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
19. Korostoff J, Wang J, Sarment D, Stewart J, Feldman R, Billings P. Analysis of in situ protease activity in chronic adult periodontitis patients: Expression of activated MMP-2 and a 40 kDa serine protease. J Periodontol 2000;71:353-360.
20. Sarment DP, Korostoff J, D'Angelo M, Polson AM, Feldman RS, Billings PC. In situ localization and characterization of active proteases in chronically inflamed and healthy human gingival tissues. J Periodontol 1999;70:1303-1312.
21. Ejeil A, Igondjo-Tchen S, Ghomrasseni S, Pellat B, Godeau G, Gogly B. Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva. J Periodontol 2003;74:188-195.
22. Sorsa T, Tjäderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 2004;10:311-318.
23. Chen H, Cox S, Eley B, Mäntylä P, Rönkä H, Sorsa T. Matrix metalloproteinase-8 levels and elastase activities in gingival crevicular fluid from chronic adult periodontitis patients. J Clin Periodontol 2000;27:366-369.
24. Haerian A, Adonogianaki E, Mooney J, Docherty J, Kinane D. Gingival crevicular stromelysin, collagenase and tissue inhibitor of metalloproteinases levels in healthy and diseased sites. J Clin Periodontol 1995;22:505-509.
25. Kinane D, Darby I, Said S, et al. Changes in gingival crevicular fluid matrix metalloproteinase-8 levels during periodontal treatment and maintenance. J Periodontal Res 2003;38:400-404.
26. Kumar M, Vamsi G, Sripriya R, Sehgal P. Expression of matrix metalloproteinases (MMP-8 and -9) in chronic periodontitis patients with and without diabetes mellitus. J Periodontol 2006;77:1803-1808.
27. Kivelä-Rajamäki M, Maisi P, Srinivas R, et al. Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid. J Periodontal Res 2003;38:583-590.
28. Tervahartiala T, Pirilä E, Ceponis A, et al. The in vivo expression of the collagenolytic matrix metalloproteinases (MMP-2, -8, -13, and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis. J Dent Res 2000;79:1969-1977.
29. Bhide V, Smith L, Overall C, Birek P, McCulloch C. Use of a fluorogenic septapeptide matrix metalloproteinase assay to assess responses to periodontal treatment. J Periodontol 2000;71:690-700.
30. Breckon JJ, Papaioannou S, Kon LW, et al. Stromelysin (MMP-3) synthesis is up-regulated in estrogen-deficient mouse osteoblasts in vivo and in vitro. J Bone Miner Res 1999;14:1880-1890.
31. Zeitler P, Pahnke J, Marx A. Expression of stromelysin-1 (MMP-3), gelatinase B (MMP-9), and plasminogen activator system during fetal calvarial development. Histopathology 2004;44:360-366.
32. Sasaki K, Takagi M, Konttinen YT, et al. Upregulation of matrix metalloproteinase (MMP)-1 and its activator MMP-3 of human osteoblast by uniaxial cyclic stimulation. J Biomed Mater Res B Appl Biomater 2007;80:491-498.
33. Hou P, Troen T, Ovejero MC, et al. Matrix metalloproteinase-12 (MMP-12) in osteoclasts: New lesson on the involvement of MMPs in bone resorption. Bone 2004;34:37-47.
34. Ishibashi O, Niwa S, Kadoyama K, Inui T. MMP-9 antisense oligodeoxynucleotide exerts an inhibitory effect on osteoclastic bone resorption by suppressing cell migration. Life Sci 2006;79:1657-1660.
35. Chen YE. MMP-12, an old enzyme plays a new role in the pathogenesis of rheumatoid arthritis? Am J Pathol 2004;165:1069-1070.
36. Lamster IB, Ahlo JK. Analysis of gingival crevicular fluid as applied to the diagnosis of oral and systemic diseases. Ann N Y Acad Sci 2007;1098:216-229.
37. Takahashi K, Ohyama H, Kitanaka M, et al. Heterogeneity of host immunological risk factors in patients with aggressive periodontitis. J Periodontol 2001;72:425-437.
38. Albandar JM, Tinoco EM. Global epidemiology of periodontal diseases in children and young persons. Periodontol 2000 2002;29:153-176.